跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CONCERTA methylphenidate hydrochloride 36mg extended release tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CONCERTA methylphenidate hydrochloride 36mg extended release tablet bottle
Approved
STANDARD
CONCERTA methylphenidate hydrochloride 36mg extended release tablet bottle
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
94653e2f71ec38a2
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
94653e2f71ec38a2
Product Name
CONCERTA methylphenidate hydrochloride 36mg extended release tablet bottle
Artg Id
93863
Artg Name
CONCERTA methylphenidate hydrochloride 36mg modified release tablet bottle
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2003-09-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-CMI-00921-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2009-PI-00919-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
94653e2f71ec38a2
Type
Standard
Back to TGA Approvals